
    
      This is a multi-center, prospective, open label, non-randomized study which will use a
      within-patient control (each patient serves as his/her own control) to document patient
      outcomes, including effectiveness, safety, and health economic data for the Boston Scientific
      implantable deep brain stimulation (DBS) Verciseâ„¢ system for bilateral stimulation of the
      subthalamic nucleus (STN) in the treatment of moderate to severe idiopathic Parkinson's
      Disease (PD).
    
  